Evidence map›Paper›PMID 30231990›Full record

Trial reportOsteoarthritis and cartilage2018

Lack of beneficial effects of low-dose radiation therapy on hand osteoarthritis symptoms and inflammation: a randomised, blinded, sham-controlled trial.

M J M Minten, M M Leseman-Hoogenboom, M Kloppenburg, M C Kortekaas, J W Leer, P M P Poortmans, F H J van den Hoogen, A A den Broeder, C H M van den Ende

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Osteoarthritis and cartilage, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04424628 (Three vs Six Gy in Gonarthrosis and Coxarthrosis. Non Inferiority Study), which is not on this map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04424628 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Three vs Six Gy in Gonarthrosis and Coxarthrosis. Non Inferiority Study

TypeinterventionalSponsorFundacion GenesisCareRan2019 to 2023Enrolled338ConditionsGonarthrosis, CoxarthrosisArmsLow dose radiotherapy A, Low dose radiotherapy B
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Implementing a low-dose radiation therapy program for musculoskeletal pain disorders: tips, tricks, and essentials for clinical researchers.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  13. Article
  14. Radiotherapy for painful shoulder syndrome: a retrospective evaluation.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2025
    Article
  15. Review
  16. Low-dose Radiation Therapy (LDRT) in Managing Osteoarthritis: A Comprehensive Review.Current therapeutic research, clinical and experimental · 2025
    Review
  17. Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002).Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2024
    Article
  18. Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

M J M MintenDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands. Electronic address: m.minten@maartenskliniek.nl.
M M Leseman-HoogenboomDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Tilly.Leseman-Hoogenboom@radboudumc.nl.
M KloppenburgDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: G.Kloppenburg@lumc.nl.
M C KortekaasDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; Department of Rheumatology, Flevoziekenhuis, Almere, The Netherlands. Electronic address: M.C.Kortekaas@lumc.nl.
J W LeerDepartment of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: janwillemleer@gmail.com.
P M P PoortmansDepartment of Radiation Oncology, Institut Curie, Paris, France. Electronic address: philip.poortmans@curie.fr.
F H J van den HoogenDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: F.vandenHoogen@maartenskliniek.nl.
A A den BroederDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: A.denbroeder@maartenskliniek.nl.
C H M van den EndeDepartment of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands; Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: E.vandenende@maartenskliniek.nl.
Radboud University Nijmegen · NLLeiden University Medical Center · NLInstitut Curie · FRSint Maartenskliniek · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesLow-dose radiation therapy (LDRT) is widely used as treatment for osteoarthritis (OA) in some countries, while relatively unknown in others. Systematic literature review displayed a lack of high-level evidence for beneficial effects in clinical practice. The aim was to assess the efficacy of LDRT on symptoms and inflammation in hand OA patients in a randomised, blinded, sham-controlled trial, using validated outcome measures.

designHand OA patients, ≥50 years, with pain ≥5 (scale 0-10) and non-responding to conservative therapy were included and randomised 1:1 to receive LDRT (6 × 1 Gy in 2 weeks) or sham (6 × 0 Gy in 2 weeks). Primary outcome was the proportion of OMERACT-OARSI responders, 3 months post-intervention. Secondary outcomes were pain and functioning (Australian/Canadian Hand Osteoarthritis Index; AUSCAN), quality of life (Short Form Health Survey; SF36) and inflammatory outcomes: erythrocyte sedimentation rate and C-reactive protein serum levels, effusion, synovial thickening and power Doppler signal on ultrasound (range 0-3).

resultsFifty-six patients were included. After 3 months, no significant difference in responders was observed between groups (LDRT: 8 (29%); sham: 10 (36%); difference -7% (95%CI -31-17%)). Also, differences in clinical and inflammatory outcomes between groups were small and not significant.

conclusionsWe were unable to demonstrate a substantial beneficial effect of LDRT on symptoms and inflammation in patients with hand OA, compared to sham treatment. Although a small effect can not be excluded, a treatment effect exceeding 20% is very unlikely, given the confidence interval. Therefore, in the absence of other high-level evidence, we advise against the use LDRT as treatment for patients with hand OA. CLINICAL TRIAL REGISTRATION NUMBER: NTR4574 (Dutch Trial Register).

Indexed as

Hand JointsAgedC-Reactive ProteinDose-Response Relationship, RadiationDouble-Blind MethodFemaleFollow-Up StudiesHumansInflammationMaleMiddle AgedOsteoarthritisQuality of LifeRadiotherapy DosageRetrospective StudiesSynovial MembraneC-Reactive ProteinClinical trialEpidemiologyInflammationOsteoarthritis handTreatment

Identifiers

PMID30231990
OpenAlexW2844450453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.